Additionally, high GABARAPL1 expression has been linked to poor prognosis in TNBC and HNSC, yet paradoxically, elevated expression correlates with longer overall survival in certain cancers, including hepatocellular carcinoma and lymph node-positive breast cancer (109, 111, 114, 115). Here, GABARAPL1 is linked to hepatocellular carcinoma.